BiomX Inc (PHGE)
0.357
-0.01
(-2.19%)
USD |
NYAM |
May 22, 16:00
0.3499
-0.01
(-1.99%)
After-Hours: 20:00
BiomX Cash from Investing (Quarterly): 0.663M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.663M |
December 31, 2023 | -0.006M |
September 30, 2023 | -0.032M |
June 30, 2023 | -0.001M |
March 31, 2023 | 1.99M |
December 31, 2022 | 1.468M |
September 30, 2022 | 4.499M |
June 30, 2022 | 1.946M |
March 31, 2022 | -10.02M |
December 31, 2021 | -0.103M |
September 30, 2021 | -1.311M |
Date | Value |
---|---|
June 30, 2021 | 12.42M |
March 31, 2021 | 5.168M |
December 31, 2020 | -9.808M |
September 30, 2020 | -0.193M |
June 30, 2020 | -0.527M |
March 31, 2020 | -0.329M |
September 30, 2019 | 0.1703M |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | -70.00M |
September 30, 2018 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-10.02M
Minimum
Mar 2022
12.42M
Maximum
Jun 2021
0.3154M
Average
-0.001M
Median
Jun 2023
Cash from Investing (Quarterly) Benchmarks
Taro Pharmaceutical Industries Ltd | -57.20M |
InspireMD Inc | 4.817M |
Alpha Tau Medical Ltd | -- |
Pluri Inc | 5.668M |
Holdco Nuvo Group DG Ltd | -- |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -11.36M |
Cash from Financing (Quarterly) | 38.98M |
Free Cash Flow | -27.60M |
Free Cash Flow Per Share (Quarterly) | -0.1823 |
Free Cash Flow Yield | -131.5% |